My Goodlife
Paris, Île-de-France Region, 75008, France
NCT Number: NCT02719925
The goal of clinical trial is to evaluate the effect of one month of consumption of mineral water rich in magnesium or not on perceived stress, duration and quality of sleep in healthy consumers having magnesium daily intakes below the recommended dietary allowance (RDA).
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Paris, Île-de-France Region, 75008, France
This is a single-center, double-blind, controlled, randomized, 2 parallel-groups clinical trial.
256 healthy volunteers will be recruited for clinical trial if they meet the inclusion and no inclusion criteria.
50% of volunteers (Mg+ group) will drink daily 1,5 L of mineral water rich in magnesium during 30 days
50% of volunteers (Mg- group) will drink daily 1,5 L of water low in magnesium during 30 days
Volunteers in both groups will be equipped with a wristband-connected device allowing recording of duration and quality of sleep.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1,5 L water per day during 30 days No lifestyle counseling
Time frame: At Day 30
Difference of score obtained at PSS self-administrated questionnaire at Day 30 and Day 0
Time frame: At Day 30
Difference of score obtained at IPAQ self-administrated questionnaire at Day 30 and Day 0
Time frame: At week 4
Difference of the mean duration of sleep during the week before consumption of water and during the fourth week of consumption of water.
Time frame: At week 4
Difference of the mean quality of sleep during the week before consumption of water and during the fourth week of consumption of water.
My Goodlife SAS
Industry
Effect of One Month of Daily Consumption of Mineral Water Rich in Magnesium on Perceived Stress in Healthy Consumers.
Acronym: STRESSOM15
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05630339
Avitaminosis, COVID-19
Durango, Mexico
View Trial DetailsNCT04130620
Deficiency Diseases, Magnesium Deficiency
Warwick, Rhode Island, United States
View Trial DetailsNCT04972344
Deficiency Diseases, Magnesium Deficiency
Seongnam-si, Gyeonggi-do, South Korea
View Trial DetailsNCT03134417
Avitaminosis, Body Weight
Philadelphia, Pennsylvania, United States
View Trial Details